Monday, 21 October 2019

GSK to sell two travel vaccines to Danish biotech firm

GlaxoSmithKline Plc said on Monday it will sell two travel vaccines to Denmark-based biotechnology company Bavarian Nordic for an upfront payment of 301 million euros ($335.71 million).


No comments:

Post a Comment